We are live on
!
Find out more
SMC
Smith, Moore & Co Portfolio holdings
AUM
$1.54B
1-Year Est. Return
24.82%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+24.82%
3 Year Est. Return
+67.03%
5 Year Est. Return
+71.32%
10 Year Est. Return
+222.13%
AUM
$439M
AUM Growth
+$40M
(+10%)
Cap. Flow
+$16.2M
Cap. Flow
% of AUM
3.68%
Top 10 Holdings %
Top 10 Hldgs %
33.85%
Holding
366
New
26
Increased
205
Reduced
72
Closed
13
Avg Time Held
8.7
quarters
Top 10 Avg Time Held
12.9
quarters
Top 20 Avg Time Held
13.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$2.08M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.19M |
| 3 |
Hershey
HSY
|
+$764K |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$624K |
| 5 |
iShares MSCI EAFE Min Vol Factor ETF
EFAV
|
+$587K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$959K |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$533K |
| 3 |
NextEra Energy, Inc.
NEE.PRQ
|
+$403K |
| 4 |
America's Car Mart
CRMT
|
+$310K |
| 5 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
+$297K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 62.16% |
| 2 | Healthcare | 7.12% |
| 3 | Consumer Staples | 4.99% |
| 4 | Industrials | 4.98% |
| 5 | Technology | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Norfolk Southern
NSC
$72.1B
| $558K | 0.13% |
3,091
+103
| +3% | +$17.6K |
2016 Q1
10 quarters
|
|
152
Citigroup
C
$209B
| $556K | 0.13% |
7,745
+140
| +2% | +$9.9K |
2017 Q3
4 quarters
|
|
153
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.3B
| $546K | 0.12% |
15,111
| – | – |
2013 Q4
19 quarters
|
|
154
State Street SPDR S&P Dividend ETF
SDY
$21B
| $543K | 0.12% |
5,545
-241
| -4% | -$23.4K |
2017 Q3
4 quarters
|
|
155
Qualcomm
QCOM
$189B
| $530K | 0.12% |
7,353
-337
| -4% | -$22.2K |
2014 Q4
15 quarters
|
|
156
AB InBev
BUD
$155B
| $527K | 0.12% |
6,022
+1,481
| +33% | +$144K |
2017 Q1
6 quarters
|
|
157
abrdn Asia-Pacific Income Fund
FAX
$529M
| $527K | 0.12% |
21,198
+7,495
| +55% | +$191K |
2013 Q4
19 quarters
|
|
158
iShares US Medical Devices ETF
IHI
$3.65B
| $524K | 0.12% |
13,812
+516
| +4% | +$18.3K |
2017 Q2
5 quarters
|
|
|
KSU
159
DELISTED
Kansas City Southern
KSU
| $523K | 0.12% |
4,617
+473
| +11% | +$53.9K |
2016 Q1
10 quarters
|
|
160
Enterprise Financial Services Corp
EFSC
$2.14B
| $520K | 0.12% |
9,793
-419
| -4% | -$23.3K |
2016 Q3
8 quarters
|
|
161
Corning
GLW
$128B
| $516K | 0.12% |
14,617
+3,834
| +36% | +$125K |
2016 Q2
9 quarters
|
|
|
CERN
162
DELISTED
Cerner Corp
CERN
| $516K | 0.12% |
8,013
+517
| +7% | +$32.9K |
2013 Q4
19 quarters
|
|
163
Canadian National Railway
CNI
$71.8B
| $514K | 0.12% |
5,726
-251
| -4% | -$21.9K |
2017 Q1
6 quarters
|
|
164
DELISTED
Leggett & Platt
LEG
| $514K | 0.12% |
11,749
+935
| +9% | +$42K |
2014 Q2
17 quarters
|
|
165
ESCO Technologies
ESE
$6.75B
| $507K | 0.12% |
7,444
+84
| +1% | +$5.45K |
2014 Q3
16 quarters
|
|
166
GSK
GSK
$92.7B
| $507K | 0.12% |
10,089
+247
| +3% | +$12.5K |
2016 Q2
9 quarters
|
|
167
Saba Capital Income & Opportunities Fund II
SABA
$207M
| $507K | 0.12% |
41,462
+1,804
| +5% | +$22.1K |
2013 Q4
19 quarters
|
|
168
Royal Gold
RGLD
$19.8B
| $504K | 0.11% |
6,540
-640
| -9% | -$52.7K |
2017 Q3
4 quarters
|
|
169
Belden
BDC
$4.24B
| $502K | 0.11% |
7,036
-514
| -7% | -$35.3K |
2018 Q2
1 quarter
|
|
170
WEC Energy
WEC
$34.5B
| $498K | 0.11% |
7,465
+102
| +1% | +$6.8K |
2013 Q4
19 quarters
|
|
171
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.29B
| $493K | 0.11% |
7,852
+396
| +5% | +$25.1K |
2018 Q1
2 quarters
|
|
172
Exelon
EXC
$43.6B
| $492K | 0.11% |
15,812
-63
| -0.4% | -$1.94K |
2017 Q2
5 quarters
|
|
173
Vanguard Short-Term Bond ETF
BSV
$45.4B
| $490K | 0.11% |
6,278
-564
| -8% | -$44.1K |
2017 Q3
4 quarters
|
|
174
CSX Corp
CSX
$88.5B
| $489K | 0.11% |
19,827
+468
| +2% | +$11.1K |
2018 Q1
2 quarters
|
|
175
Bank of New York Mellon
BNY
$95.7B
| $484K | 0.11% |
9,498
-42
| -0.4% | -$2.21K |
2017 Q3
4 quarters
|
|
Similar funds
AWC
FP
SPC
LCM
CP
KCM
HCM
BFG
Smith, Moore & Co's Q3 2018 Portfolio in Review
As of Q3 2018, Smith, Moore & Co held 366 positions worth $439M, up 10% from $399M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Smith, Moore & Co deployed $16.2M of net new capital in Q3 2018, opening 26 new positions and adding to 205 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 18,056 shares worth $2.15M.
By sector, the portfolio is most concentrated in Miscellaneous at 62% of assets, down from 64% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Express Scripts Holding Company, an estimated $533K trimmed.
- Smith, Moore & Co's largest Q3 2018 buy was iShares MSCI USA Momentum Factor ETF: 18,056 shares worth $2.15M.
- Smith, Moore & Co added most to Vanguard Short-Term Corporate Bond ETF in Q3 2018, an estimated $1.19M increase.
- Smith, Moore & Co's biggest Q3 2018 reduction was Express Scripts Holding Company, cutting an estimated $533K.
- Smith, Moore & Co fully exited iShares Core MSCI EAFE ETF in Q3 2018, selling an estimated $959K.
- Smith, Moore & Co's ten largest holdings make up 34% of its $439M portfolio in Q3 2018.
- Smith, Moore & Co opened 26 new positions and closed 13 in Q3 2018.
- Smith, Moore & Co's portfolio value rose 10% quarter-over-quarter to $439M.
Based on Smith, Moore & Co's 13F filing for Q3 2018, filed 15 Nov 2018.